Diagnostic Procedures in Respiratory Disease¶
Chapter 297 | Part 7: Disorders of the Respiratory System
KEY CLINICAL POINTS¶
- Spirometry is essential for assessing airflow obstruction, with FEV1/FVC ratio being a key diagnostic marker.
- Imaging modalities (CXR, CT, MRI, PET) are critical for evaluating structural abnormalities and functional assessment of lung disease.
- Bronchoscopy and transbronchial biopsy (including EBUS-TBNA) are vital for diagnosing parenchymal lung diseases and malignancies.
- Arterial blood gas analysis and diffusing capacity (DLCO) provide insights into gas exchange and pulmonary vascular health.
- Artificial intelligence and deep learning are emerging tools for enhancing diagnostic accuracy in thoracic imaging.
1. DEFINITION & OVERVIEW¶
Diagnostic procedures in respiratory disease encompass invasive and non-invasive methods to evaluate lung function, structure, and pathology. These include spirometry, arterial blood gas analysis, imaging techniques, bronchoscopy, and pleural procedures. The goal is to assess airflow obstruction, gas exchange, and structural abnormalities while guiding therapeutic interventions.
Diffusing Capacity (DLCO) Interpretation¶
| Parameter | Normal Range | Clinical Implication |
|---|---|---|
| DLCO (mL/min/mmHg) | 25–35 | Reduced in interstitial lung disease, pulmonary fibrosis, or anemia |
| DLCO/VA Ratio | 25–35% | Decreased in restrictive lung disease or pulmonary vascular disease |
1.1 Spirometry and Lung Volumes¶
Spirometry measures airflow dynamics (FVC, FEV1) and lung volumes (TLC, RV, FRC). The FEV1/FVC ratio helps distinguish obstructive vs. restrictive lung disease. Normal lung volumes scale with height, age, and sex, with predicted values calculated using multivariate regression equations.
1.2 Arterial Blood Gases and Diffusing Capacity¶
Arterial blood gases (ABG) assess oxygenation (PaO2), carbon dioxide retention (PaCO2), and acid-base balance. Diffusing capacity (DLCO) measures gas exchange efficiency, influenced by alveolar membrane thickness, hemoglobin, and pulmonary capillary blood flow.
2. EPIDEMIOLOGY¶
Lung volumes and airflow obstruction vary with age, sex, and height. Risk factors for obstructive lung disease include smoking, environmental exposures, and comorbidities like COPD or asthma. Restrictive diseases (e.g., interstitial lung disease) are more common in older adults and those with connective tissue disorders.
2.1 Demographics¶
Lung volumes increase with height and decrease with age. Women typically have smaller lung volumes than men of similar height. Obstructive lung disease is more prevalent in smokers and individuals with occupational exposures.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Airflow obstruction arises from peripheral (e.g., asthma, emphysema) or central (e.g., tumors, vocal cord paralysis) airway disease. Restrictive lung disease results from parenchy-mal fibrosis, pleural effusion, or neuromuscular disorders. Gas exchange impairment occurs due to alveolar membrane thickening, reduced capillary perfusion, or hemoglobin abnormalities.
3.1 Mechanisms of Airflow Obstruction¶
Obstructive lung disease involves narrowing of small airways (e.g., asthma, COPD) or large airways (e.g., tumors, tracheal stenosis). Fixed obstruction (e.g., vocal cord paralysis) leads to flow plateaus on flow-volume loops, while variable obstruction (e.g., asthma) causes "scooping" of the loop.
4. CLINICAL FEATURES¶
Symptoms of respiratory disease include dyspnea, cough, and sputum production. Signs may involve wheezing, crackles, or cyanosis. Complications of chronic disease include respiratory failure, pulmonary hypertension, and recurrent infections.
4.1 Differential Diagnosis¶
Differential diagnosis includes asthma, COPD, interstitial lung disease, pulmonary fibrosis, and tumors. Imaging and bronchoscopy help distinguish between parenchymal, vascular, and pleural pathologies.
5. INVESTIGATIONS & DIAGNOSIS¶
Diagnostic investigations include spirometry, imaging (CXR, CT, MRI), bronchoscopy, and laboratory tests (ABG, DLCO). Algorithms guide the selection of procedures based on clinical suspicion and findings.
Diagnostic Yield of Transbronchial Procedures¶
| Procedure | Sensitivity (%) | Specificity (%) |
|---|---|---|
| Transbronchial Biopsy | 70–80 | 85–90 |
| EBUS-TBNA | 90 | 70 (for lymphoma) |
| Cryobiopsy | 80–90 | N/A |
5.1 Imaging Modalities¶
Chest X-ray (CXR) provides initial assessment of lung parenchyma, while CT offers detailed structural evaluation. MRI is used for soft tissue contrast, and PET detects metabolic activity in tumors.
5.2 Bronchoscopy and Biopsy¶
Flexible bronchoscopy accesses central airways, while rigid bronchoscopy provides airway stabilization. Transbronchial biopsy (TBNA) and EBUS-TBNA are used for mediastinal and peripheral lung sampling.
6. MANAGEMENT & TREATMENT¶
Management involves pharmacologic (bronchodilators, corticosteroids), non-pharmacologic (pulmonary rehabilitation), and surgical interventions (thoracoscopy, VATS). Bronchoscopy and TBNA are used for biopsy and therapeutic interventions.
6.1 Bronchoscopy Techniques¶
Flexible bronchoscopy is used for diagnostic sampling, while rigid bronchoscopy provides airway access for cryobiopsy or foreign body removal. EBUS-TBNA is preferred for mediastinal lymph node sampling.
7. PROGNOSIS & COMPLICATIONS¶
Prognosis depends on disease severity, response to therapy, and comorbidities. Complications include pneumothorax, bleeding, and infection. Early diagnosis and intervention improve outcomes in conditions like interstitial lung disease or lung cancer.
7.1 Complications of Diagnostic Procedures¶
Pneumothorax (17–28% with TTNA), hemoptysis, and bleeding are common risks. MRI and CT carry radiation exposure, while bronchoscopy may cause airway trauma.
8. SPECIAL CONSIDERATIONS¶
Pregnancy, pediatrics, and elderly patients require tailored approaches. For example, thoracoscopy in pregnant patients avoids radiation, and bronchoscopy in children uses smaller instruments. Elderly patients may have reduced lung compliance and increased risk of complications.
8.1 Pediatric Considerations¶
Pediatric bronchoscopy uses flexible scopes with smaller working channels. Sputum induction is preferred over bronchoscopy in children with suspected infection.
9. KEY POINTS & CLINICAL PEARLS¶
- Spirometry is the cornerstone of airflow obstruction assessment. 2. CT and MRI are essential for structural evaluation of lung disease. 3. EBUS-TBNA is the gold standard for mediastinal lymph node sampling. 4. Bronchoscopy and TBNA are critical for diagnosing peripheral lung lesions. 5. Artificial intelligence enhances diagnostic accuracy in thoracic imaging.